Kurt R. Auger

8.3k total citations · 2 hit papers
33 papers, 5.4k citations indexed

About

Kurt R. Auger is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Kurt R. Auger has authored 33 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Cell Biology. Recurrent topics in Kurt R. Auger's work include Ubiquitin and proteasome pathways (7 papers), Cancer-related Molecular Pathways (6 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Kurt R. Auger is often cited by papers focused on Ubiquitin and proteasome pathways (7 papers), Cancer-related Molecular Pathways (6 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Kurt R. Auger collaborates with scholars based in United States, United Kingdom and France. Kurt R. Auger's co-authors include Lewis C. Cantley, Stephen P. Soltoff, Brian Duckworth, Andrea Graziani, Rosana Kapeller, Christopher Carpenter, Leslie A. Serunian, Peter Libby, Thomas M. Roberts and Robert A. Copeland and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Kurt R. Auger

33 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oncogenes and signal transduction

1991 2.5k citations Lewis C. Cantley, Kurt R. Auger et al. Cell profile →
PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells

1989 809 citations Kurt R. Auger, Leslie A. Serunian et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kurt R. Auger United States	22	4.1k	1.3k	1.0k	661	409	33	5.4k
Rosana Kapeller United States	26	4.1k 1.0×	1.1k 0.8×	1.0k 1.0×	1.0k 1.5×	378 0.9×	41	5.9k
Brian Duckworth United States	12	3.4k 0.8×	914 0.7×	1.2k 1.1×	926 1.4×	399 1.0×	15	4.9k
Ritu Dhand United Kingdom	21	4.8k 1.2×	1.0k 0.8×	1.5k 1.4×	865 1.3×	365 0.9×	26	6.1k
Henrik Daub Germany	35	5.4k 1.3×	1.7k 1.3×	1.1k 1.1×	705 1.1×	453 1.1×	56	7.6k
Peter Blume‐Jensen United States	18	3.3k 0.8×	1.3k 1.0×	568 0.6×	840 1.3×	332 0.8×	25	5.0k
Serge Roche France	37	3.1k 0.8×	1.0k 0.8×	839 0.8×	509 0.8×	373 0.9×	92	4.5k
Jane McGlade Canada	23	5.0k 1.2×	1.4k 1.1×	1.1k 1.1×	1.2k 1.8×	552 1.3×	26	6.6k
Reiner Lammers Germany	39	4.6k 1.1×	1.1k 0.8×	981 1.0×	1.3k 1.9×	349 0.9×	75	6.1k
Jaime A. Escobedo United States	26	5.4k 1.3×	1.2k 0.9×	998 1.0×	771 1.2×	748 1.8×	38	7.0k
Deborah H. Anderson Canada	24	2.8k 0.7×	732 0.6×	780 0.8×	641 1.0×	302 0.7×	59	3.9k

Countries citing papers authored by Kurt R. Auger

Since Specialization

Citations

This map shows the geographic impact of Kurt R. Auger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt R. Auger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt R. Auger more than expected).

Fields of papers citing papers by Kurt R. Auger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt R. Auger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt R. Auger. The network helps show where Kurt R. Auger may publish in the future.

Co-authorship network of co-authors of Kurt R. Auger

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt R. Auger. A scholar is included among the top collaborators of Kurt R. Auger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt R. Auger. Kurt R. Auger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mak, Gabriel, Jean‐Charles Soria, Sarah P. Blagden, et al.. (2019). A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumours. British Journal of Cancer. 120(10). 975–981. 69 indexed citations

Brown, Nicholas F., Matthew Williams, Hendrik‐Tobias Arkenau, et al.. (2018). A study of the focal adhesion kinase inhibitor GSK2256098 in patients with recurrent glioblastoma with evaluation of tumor penetration of [11C]GSK2256098. Neuro-Oncology. 20(12). 1634–1642. 54 indexed citations

Mulholland, Paul, Matthew Williams, Hendrik‐Tobias Arkenau, et al.. (2015). ATNT-06EVALUATION OF THE SAFETY OF GSK2256098 AND PHARMACOKINETICS OF¹¹C-GSK2256098 IN PATIENTS WITH RECURRENT GLIOBLASTOMA BY POSITRON EMISSION TOMOGRAPHY (PET) IMAGING. Neuro-Oncology. 17(suppl 5). v11.2–v11. 3 indexed citations

Arkenau, Hendrik‐Tobias, Anas Gazzah, Ruth Plummer, et al.. (2015). A phase Ib dose-escalation study of GSK2256098 (FAKi) plus trametinib (MEKi) in patients with selected advanced solid tumors.. Journal of Clinical Oncology. 33(15_suppl). 2593–2593. 4 indexed citations

Brown, James R. & Kurt R. Auger. (2011). Phylogenomics of phosphoinositide lipid kinases: perspectives on the evolution of second messenger signaling and drug discovery. BMC Evolutionary Biology. 11(1). 4–4. 84 indexed citations

Greshock, Joel, Kurtis E. Bachman, Yan Degenhardt, et al.. (2010). Molecular Target Class Is Predictive of In vitro Response Profile. Cancer Research. 70(9). 3677–3686. 100 indexed citations

Zhang, Yan, Michael J. Italia, Kurt R. Auger, et al.. (2010). Molecular Evolutionary Analysis of Cancer Cell Lines. Molecular Cancer Therapeutics. 9(2). 279–291. 6 indexed citations

Luo, Lusong, Cynthia A. Parrish, Neysa Nevins, et al.. (2007). ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanism. Nature Chemical Biology. 3(11). 722–726. 92 indexed citations

Auger, Kurt R., Robert A. Copeland, & Zhihong Lai. (2005). Quantitative Assays of Mdm2 Ubiquitin Ligase Activity and Other Ubiquitin‐Utilizing Enzymes for Inhibitor Discovery. Methods in enzymology on CD-ROM/Methods in enzymology. 399. 701–717. 5 indexed citations

10.

Lai, Zhihong, Melody Diamond, Young B. Kim, et al.. (2001). Human mdm2 Mediates Multiple Mono-ubiquitination of p53 by a Mechanism Requiring Enzyme Isomerization. Journal of Biological Chemistry. 276(33). 31357–31367. 128 indexed citations

11.

Lai, Zhihong, Kurt R. Auger, Jianhong Ma, et al.. (2000). Steady-State Kinetic Analysis of Human Ubiquitin-Activating Enzyme (E1) Using a Fluorescently Labeled Ubiquitin Substrate. Journal of Protein Chemistry. 19(6). 489–498. 21 indexed citations

12.

Alberta, John A., Kurt R. Auger, David Batt, et al.. (1999). Platelet-derived Growth Factor Stimulation of Monocyte Chemoattractant Protein-1 Gene Expression Is Mediated by Transient Activation of the Phosphoinositide 3-Kinase Signal Transduction Pathway. Journal of Biological Chemistry. 274(43). 31062–31067. 23 indexed citations

13.

Chang, Hwai Wen, Masahiro Aoki, Kurt R. Auger, et al.. (1997). Transformation of Chicken Cells by the Gene Encoding the Catalytic Subunit of PI 3-Kinase. Science. 276(5320). 1848–1850. 360 indexed citations

14.

Auger, Kurt R., Zhou Songyang, Su Hao Lo, Thomas M. Roberts, & Lan Bo Chen. (1996). Platelet-derived Growth Factor-induced Formation of Tensin and Phosphoinositide 3-Kinase Complexes. Journal of Biological Chemistry. 271(38). 23452–23457. 48 indexed citations

15.

Wang, Jing, Kurt R. Auger, Lesley A. Jarvis, Yang Shi, & Thomas M. Roberts. (1995). Direct Association of Grb2 with the p85 Subunit of Phosphatidylinositol 3-Kinase. Journal of Biological Chemistry. 270(21). 12774–12780. 96 indexed citations

16.

Carpenter, Christopher L., Kurt R. Auger, Brian Duckworth, et al.. (1993). A Tightly Associated Serine/Threonine Protein Kinase Regulates Phosphoinositide 3-Kinase Activity. Molecular and Cellular Biology. 13(3). 1657–1665. 181 indexed citations

17.

Domchek, Susan M., Kurt R. Auger, Swati Chatterjee, Terrence R. Burke, & Steven E. Shoelson. (1992). Inhibition of SH2 domain/phosphoprotein association by a nonhydrolyzable phosphonopeptide. Biochemistry. 31(41). 9865–9870. 117 indexed citations

18.

Serunian, Leslie A., Kurt R. Auger, & Lewis C. Cantley. (1991). Identification and quantification of polyphosphoinositides produced in response to platelet-derived growth factor stimulation. Methods in enzymology on CD-ROM/Methods in enzymology. 198. 78–87. 135 indexed citations

19.

Cantley, Lewis C., Kurt R. Auger, Christopher Carpenter, et al.. (1991). Oncogenes and signal transduction. Cell. 64(2). 281–302. 2457 indexed citations breakdown →

20.

Auger, Kurt R., Leslie A. Serunian, Stephen P. Soltoff, Peter Libby, & Lewis C. Cantley. (1989). PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell. 57(1). 167–175. 809 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact